Literature DB >> 20385430

Combination of acarbose and ezetimibe prevents non-alcoholic fatty liver disease: a break of intestinal insulin resistance?

Natalia N Rudovich, Martin O Weickert, Juergen Machann, Andreas F H Pfeiffer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20385430     DOI： 10.1016/j.jhep.2010.02.004

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  6 in total

1.  Ezetimibe in the balance: can cholesterol-lowering drugs alone be an effective therapy for NAFLD?

Authors:  Giovanni Musso
Journal:  Diabetologia       Date:  2014-02-20       Impact factor: 10.122

2.  Nutritional strategy to prevent fatty liver and insulin resistance independent of obesity by reducing glucose-dependent insulinotropic polypeptide responses in mice.

Authors:  Farnaz Keyhani-Nejad; Martin Irmler; Frank Isken; Eva K Wirth; Johannes Beckers; Andreas L Birkenfeld; Andreas F H Pfeiffer
Journal:  Diabetologia       Date:  2014-10-28       Impact factor: 10.122

Review 3.  Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.

Authors:  Juan P Arab; Roberto Candia; Rodrigo Zapata; Cristián Muñoz; Juan P Arancibia; Jaime Poniachik; Alejandro Soza; Francisco Fuster; Javier Brahm; Edgar Sanhueza; Jorge Contreras; M Carolina Cuellar; Marco Arrese; Arnoldo Riquelme
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 4.  NAFLD as a continuum: from obesity to metabolic syndrome and diabetes.

Authors:  Amélio F Godoy-Matos; Wellington S Silva Júnior; Cynthia M Valerio
Journal:  Diabetol Metab Syndr       Date:  2020-07-14       Impact factor: 3.320

Review 5.  Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop.

Authors:  Harry P F Peters; Patrick Schrauwen; Petra Verhoef; Christopher D Byrne; David J Mela; Andreas F H Pfeiffer; Ulf Risérus; Frits R Rosendaal; Vera Schrauwen-Hinderling
Journal:  J Nutr Sci       Date:  2017-05-08

Review 6.  Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans.

Authors:  Kalliopi Pafili; Michael Roden
Journal:  Mol Metab       Date:  2020-11-19       Impact factor: 7.422
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.